老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ascendis Pharma A/S

263.52
+2.290.87%
盤後：263.520.00000.00%19:52 EDT
成交量：44.36萬
成交額：1.17億
市值：174.42億
市盈率：20.33
高：266.34
開：263.34
低：259.48
收：261.23
52周最高：282.15
52周最低：186.05
股本：6,618.99萬
流通股本：6,553.95萬
量比：0.65
換手率：0.68%
股息：- -
股息率：- -
每股收益(TTM):12.96
每股收益(LYR):-4.4176
淨資產收益率：118.78%
總資產收益率：9.58%
市淨率：10.49
市盈率(LYR):-59.65

資料載入中...

總覽公司新聞公告
2020/12/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/08

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多